drugset / Trial / NCT00805012
Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2
Terminated
96 enrolled
Seoul National University Hospital
Clinical Research Center for Solid Tumor, Korea · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess response rate of docetaxel and S-1 combination in metastatic or recurrent head and neck squamous cell carcinoma
Timeline
- Start
- 2008-12
- Primary completion
- 2011-07
- Completion
- 2011-07
Outcome
Outcome not reported
Stopped (Enrollment): “slow accrual rate”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cisplatin | Other / unclassified | — | — |
| Comparator | Docetaxel | Small molecule | — | — |
| Subject | S-1 | Small molecule | — | — |